643 related articles for article (PubMed ID: 23436247)
1. A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer.
Satija YK; Bhardwaj A; Das S
Int J Cancer; 2013 Dec; 133(12):2759-68. PubMed ID: 23436247
[TBL] [Abstract][Full Text] [Related]
2. Dynamics in the p53-Mdm2 ubiquitination pathway.
Brooks CL; Gu W
Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
[TBL] [Abstract][Full Text] [Related]
3. Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.
Jung YS; Qian Y; Chen X
FEBS Lett; 2012 May; 586(10):1397-402. PubMed ID: 22673504
[TBL] [Abstract][Full Text] [Related]
4. p53 stability is regulated by diverse deubiquitinating enzymes.
Kwon SK; Saindane M; Baek KH
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):404-411. PubMed ID: 28801249
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
6. p53 ubiquitination: Mdm2 and beyond.
Brooks CL; Gu W
Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
[TBL] [Abstract][Full Text] [Related]
7. Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.
Sane S; Rezvani K
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218667
[TBL] [Abstract][Full Text] [Related]
8. Approaches to discovering drugs that regulate E3 ubiquitin ligases.
Huang J; Tsvetkov L; Qu K; Daniel-Issakani S; Payan DG
Ernst Schering Found Symp Proc; 2008; (1):153-70. PubMed ID: 19198069
[TBL] [Abstract][Full Text] [Related]
9. The multiple levels of regulation by p53 ubiquitination.
Lee JT; Gu W
Cell Death Differ; 2010 Jan; 17(1):86-92. PubMed ID: 19543236
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms.
de Bie P; Ciechanover A
Cell Death Differ; 2011 Sep; 18(9):1393-402. PubMed ID: 21372847
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets.
Shi D; Grossman SR
Cancer Biol Ther; 2010 Oct; 10(8):737-47. PubMed ID: 20930542
[TBL] [Abstract][Full Text] [Related]
12. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
13. Making sense of ubiquitin ligases that regulate p53.
Jain AK; Barton MC
Cancer Biol Ther; 2010 Oct; 10(7):665-72. PubMed ID: 20930521
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'.
Yamasaki S; Yagishita N; Sasaki T; Nakazawa M; Kato Y; Yamadera T; Bae E; Toriyama S; Ikeda R; Zhang L; Fujitani K; Yoo E; Tsuchimochi K; Ohta T; Araya N; Fujita H; Aratani S; Eguchi K; Komiya S; Maruyama I; Higashi N; Sato M; Senoo H; Ochi T; Yokoyama S; Amano T; Kim J; Gay S; Fukamizu A; Nishioka K; Tanaka K; Nakajima T
EMBO J; 2007 Jan; 26(1):113-22. PubMed ID: 17170702
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
16. Role of p53 circuitry in tumorigenesis: A brief review.
Niazi S; Purohit M; Niazi JH
Eur J Med Chem; 2018 Oct; 158():7-24. PubMed ID: 30199707
[TBL] [Abstract][Full Text] [Related]
17. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
18. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.
Lau AW; Fukushima H; Wei W
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2197-212. PubMed ID: 22652772
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of p53 degradation.
Chao CC
Clin Chim Acta; 2015 Jan; 438():139-47. PubMed ID: 25172038
[TBL] [Abstract][Full Text] [Related]
20. Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance.
Kubaichuk K; Kietzmann T
Cells; 2019 Jun; 8(6):. PubMed ID: 31208103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
